Report Categories
View AllRecent Articles
View All
EVLV Evolv stock notches small gain even as Q4 2025 earnings land below consensus analyst estimates
Hooker HOFT Stock Weekly Review Smart Money Flows 20260420
Communication Services Select Sector SPDR Fund XLC Leads US Equity Sector Gains Amid Geopolitical Tension Easing
Why Genius GNS earnings could be a turning point Q4 2022 Below Expectations
Green GCDT Stock Why You Should Hold It At Lows 20260420
MTEKW MarisTech warrants show muted quarterly performance with no significant surprises amid cautious investor sentiment
How C4 Thera CCCC guidance shapes future expectations CCCC Q4 2025 Earnings C4 Thera Beats Street Views as Loss Narrows
What makes ASP Isotopes ASPI a compelling holding for the long term 379 20260508
BLW Blackrock investors seek clarity on fixed income portfolio returns following its latest quarterly earnings release
EV CA Muni CEV Down 079 How Low Could It Go 20260518
NANOX NNOX Q4 2025 Disappoints EPS 050 Below 020 Views
Adamas Trust ADAMO Falls 063 Watching 2380 Support 20260519
Micron Technology Stock Surge Could AI Memory Demand Sustain the Rally
JP Morgan JPM Q1 2026 Earnings EPS 594 Beats Estimates
Merchants MBINM Q1 2026 Earnings Outperformance Signals Momentum
SREA Sempra 5750 Junior Subordinated Notes Edges Lower as Yield Environment Weighs on FixedIncome Securities
AI Frenzy Drives Over 100 Gains for Select European Stocks This Year
BKV Q1 2026 Earnings EPS Miss Marks Volatile Start
Repligen Corporation RGEN Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Not Disclosed
Elme Communities Q4 2025 Earnings Massive EPS Miss as Losses Widen Stock Edges Higher
FOXF Q1 2026 Earnings EPS Surges 115 Above Estimates Stock Rises
CRAI Q1 2026 Earnings EPS Misses Estimates Slightly Stock Edges Higher
Westamerica Bancorporation WABC Posts Modest Decline Holds Above Key Support
Nasdaq Inc NDAQ Edges Lower as Broader Market Pressure Weighs on Volume
Johnson Controls International JCI Rallies 213 as Support Holds Eyes Resistance at 14528
BioCryst Pharmaceuticals BCRX Surges 626 as Momentum Builds Above Key Support